NDC 69102-150 Subvenite
View Dosage, Usage, Ingredients, Routes, UNII
Product Information
- 69102 - Owp Pharmaceuticals, Inc.
- 69102-150 - Subvenite
Product Characteristics
9 MM
11 MM
10LA
15LA
Product Packages
Product Details
What is NDC 69102-150?
What are the uses for Subvenite?
Which are Subvenite UNII Codes?
The UNII codes for the active ingredients in this product are:
- LAMOTRIGINE (UNII: U3H27498KS)
- LAMOTRIGINE (UNII: U3H27498KS) (Active Moiety)
Which are Subvenite Inactive Ingredients UNII Codes?
The inactive ingredients are all the component of a medicinal product OTHER than the active ingredient(s). The acronym "UNII" stands for “Unique Ingredient Identifier” and is used to identify each inactive ingredient present in a product. The UNII codes for the inactive ingredients in this product are:
- LACTOSE MONOHYDRATE (UNII: EWQ57Q8I5X)
- MAGNESIUM STEARATE (UNII: 70097M6I30)
- CELLULOSE, MICROCRYSTALLINE (UNII: OP1R32D61U)
- POVIDONE K30 (UNII: U725QWY32X)
- SODIUM STARCH GLYCOLATE TYPE A POTATO (UNII: 5856J3G2A2)
What is the NDC to RxNorm Crosswalk for Subvenite?
- RxCUI: 198427 - lamoTRIgine 100 MG Oral Tablet
- RxCUI: 198427 - lamotrigine 100 MG Oral Tablet
- RxCUI: 198428 - lamoTRIgine 150 MG Oral Tablet
- RxCUI: 198428 - lamotrigine 150 MG Oral Tablet
- RxCUI: 198429 - lamoTRIgine 200 MG Oral Tablet
* Please review the disclaimer below.
Patient Education
Lamotrigine
Lamotrigine extended-release (long-acting) tablets are used with other medications to treat certain types of seizures in patients who have epilepsy. All types of lamotrigine tablets (tablets, orally disintegrating tablets, and chewable tablets) other than the extended-release tablets are used alone or with other medications to treat seizures in people who have epilepsy or Lennox-Gastaut syndrome (a disorder that causes seizures and often causes developmental delays). All types of lamotrigine tablets other than the extended-release tablets are also used to increase the time between episodes of depression, mania (frenzied or abnormally excited mood), and other abnormal moods in patients with bipolar I disorder (manic-depressive disorder; a disease that causes episodes of depression, episodes of mania, and other abnormal moods). Lamotrigine has not been shown to be effective when people experience the actual episodes of depression or mania, so other medications must be used to help people recover from these episodes. Lamotrigine is in a class of medications called anticonvulsants. It works by decreasing abnormal electrical activity in the brain.
[Learn More]
* Please review the disclaimer below.
[5] What is the Labeler Name? - Name of Company corresponding to the labeler code segment of the Product NDC.
[9] What is the Start Marketing Date? - This is the date that the labeler indicates was the start of its marketing of the drug product.
[11] What is the Listing Expiration Date? - This is the date when the listing record will expire if not updated or certified by the product labeler.
[12] What is the NDC Exclude Flag? - This field indicates whether the product has been removed/excluded from the NDC Directory for failure to respond to FDA"s requests for correction to deficient or non-compliant submissions ("Y"), or because the listing certification is expired ("E"), or because the listing data was inactivated by FDA ("I"). Values = "Y", "N", "E", or "I".